A carregar...
Challenges and shifting paradigms in clinical trials in oncology: the case for immunological and targeted therapies
The advent of immunotherapy has undoubtedly changed the current standard for cancer treatment. Immunotherapy offers the possibility of achieving excellent results—a new alternative for patients with advanced-stage or relapsed disease. Nowadays, the progress made in tumour biology has led to multiple...
Na minha lista:
| Publicado no: | Ecancermedicalscience |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cancer Intelligence
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6695130/ https://ncbi.nlm.nih.gov/pubmed/31552109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2019.936 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|